Dello Russo, Cinzia
 Distribuzione geografica
Continente #
NA - Nord America 3.913
EU - Europa 3.891
AS - Asia 2.300
SA - Sud America 488
AF - Africa 55
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.659
Nazione #
US - Stati Uniti d'America 3.824
PL - Polonia 1.127
SG - Singapore 1.040
DE - Germania 830
IT - Italia 617
CN - Cina 527
BR - Brasile 393
SE - Svezia 354
VN - Vietnam 246
FR - Francia 189
UA - Ucraina 176
GB - Regno Unito 170
FI - Finlandia 122
IN - India 116
IE - Irlanda 96
ID - Indonesia 67
HK - Hong Kong 56
JP - Giappone 51
NL - Olanda 47
CA - Canada 43
RU - Federazione Russa 42
ES - Italia 37
MX - Messico 34
AR - Argentina 31
TR - Turchia 29
BD - Bangladesh 24
IQ - Iraq 24
BE - Belgio 20
CL - Cile 20
AT - Austria 19
KR - Corea 15
SA - Arabia Saudita 14
EC - Ecuador 13
MA - Marocco 13
ZA - Sudafrica 13
AU - Australia 11
PK - Pakistan 11
CZ - Repubblica Ceca 10
MY - Malesia 10
CO - Colombia 9
IR - Iran 9
LT - Lituania 8
UZ - Uzbekistan 7
CH - Svizzera 6
EG - Egitto 6
KE - Kenya 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
JO - Giordania 5
PE - Perù 5
UY - Uruguay 5
VE - Venezuela 5
AL - Albania 4
AZ - Azerbaigian 4
IL - Israele 4
KZ - Kazakistan 4
LB - Libano 4
QA - Qatar 4
BG - Bulgaria 3
ET - Etiopia 3
GR - Grecia 3
HU - Ungheria 3
OM - Oman 3
PT - Portogallo 3
TH - Thailandia 3
BB - Barbados 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
JM - Giamaica 2
MN - Mongolia 2
NG - Nigeria 2
PY - Paraguay 2
SN - Senegal 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CR - Costa Rica 1
CY - Cipro 1
HN - Honduras 1
IS - Islanda 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MR - Mauritania 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
SO - Somalia 1
SV - El Salvador 1
ZW - Zimbabwe 1
Totale 10.659
Città #
Warsaw 1.114
Singapore 531
Ashburn 502
Chandler 393
San Jose 293
Fairfield 190
Houston 136
Jacksonville 135
Wilmington 118
Woodbridge 105
Beijing 103
San Mateo 101
Dublin 96
Verona 94
Seattle 85
Cambridge 84
Milan 83
Cattolica 82
New York 82
Ann Arbor 79
Ho Chi Minh City 78
Council Bluffs 69
Munich 69
Helsinki 66
Nanjing 66
Los Angeles 64
Rome 62
Jakarta 60
The Dalles 59
Hanoi 56
Lauterbourg 54
Hefei 52
Hong Kong 52
Bremen 48
São Paulo 48
Dearborn 46
Dallas 40
Chicago 38
Tokyo 38
Lawrence 34
Nürnberg 34
Moscow 32
Frankfurt am Main 29
Boston 28
Redwood City 28
London 26
Nanchang 24
Marseille 23
Nuremberg 23
Lancaster 22
Phoenix 21
Santa Clara 21
St Louis 21
North Bergen 19
Philadelphia 19
Princeton 18
Brussels 17
Mountain View 17
Lappeenranta 16
Manchester 16
Da Nang 15
Redmond 15
Buffalo 14
Hyderabad 14
Orem 14
Pune 14
Rio de Janeiro 14
Shanghai 14
Brasília 13
Kent 13
Paris 13
Chennai 12
Denver 12
Dong Ket 12
Montreal 12
Toronto 12
Boardman 11
Guangzhou 11
Hangzhou 11
Izmir 11
Naples 11
Salvador 11
Düsseldorf 10
Falkenstein 10
Fremont 10
Jiaxing 10
Santiago 10
Scottsdale 10
Seoul 10
Shenyang 10
Sydney 10
Baghdad 9
Leawood 9
Riyadh 9
San Diego 9
San Francisco 9
Stockholm 9
University Park 9
Brooklyn 8
Charlotte 8
Totale 6.407
Nome #
Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma 487
The human microglial HMC3 cell line: where do we stand? A systematic literature review 449
The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype 436
Monocytes from depressed patients display an altered pattern of response to endotoxin challenge 416
mTOR kinase: a possible pharmacological target in the management of chronic pain 404
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 381
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes 363
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology 358
The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1 353
Effects of remifentanil on human C20 microglial pro-inflammatory activation 272
Antiretrovirals inhibit arginase in human microglia 216
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects. 208
Buprenorphine inhibits bradykinin-induced release of calcitonin gene-related peptide from rat trigeminal neurons via both μ-opioid and nociceptin/orphanin peptide receptors. 197
The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells 188
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects 172
Remifentanil-induced hyperalgesia in healthy volunteers: a systematic review and meta-analysis of randomized controlled trials 169
Antiretrovirals inhibit arginase in human microglia 168
Stress-related biomarkers of dream recall and implicit memory under anaesthesia 167
Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120 162
Antinociceptive activity of buprenorphine and lumiracoxib in the rat orofacial formalin test: a combination analysis study. 160
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study 152
The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27Kip1 protein up-regulation and c-Myc mRNA down-regulation 152
A comparison between the assessments of progression-free survival by local investigators versus blinded independent central reviews in phase III oncology trials 150
Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells 146
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception. 145
Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. 143
Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism 143
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception 142
Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis 139
Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data 138
Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Phase 2 Oncology Trials 138
The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception 137
Comparative Analysis of Real-Time Polymerase Chain Reaction Methods to Typing HLA-B*57:01 in HIV-1-Positive Patients 136
Optimizing Patient Selection to Maximize Drug Efficacy: the Expanding Role of Pharmacogenomics in the Clinical Development of Pembrolizumab for the Treatment of Non-small Cell Lung Cancer 136
Dimethyl fumarate induced lymphopenia in multiple sclerosis: A review of the literature 135
Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation 134
Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes 130
Exploiting microglial functions for the treatment of glioblastoma 127
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function. 126
REMIFENTANIL DOES NOT AFFECT HUMAN MICROGLIAL IMMUNE ACTIVATION IN RESPONSE TO PRO-INFLAMMATORY CYTOKINES 125
Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. 125
Pro-inflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/b polarized cells 124
Noradrenaline in Alzheimer's Disease: A New Potential Therapeutic Target 120
LAT1, a novel pharmacological target for the treatment of glioblastoma 119
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis 117
Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells 117
Diffusion of complementary evolving pharmaceutical innovations: The case of Abacavir and its pharmacogenetic companion diagnostic in Italy 117
Physiological adaptations affecting drug pharmacokinetics in space: what do we really know? A critical review of the literature 117
What is the weight of expectation bias in oncology trials? 114
The Future of Personalized Medicine in Space: From Observations to Countermeasures 113
Perioperative analgesia in the elderly 111
Exploiting Microglial Functions for the Treatment of Glioblastoma 110
The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE 108
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function 108
Relationship between blood remifentanil concentration and stress hormone levels during pneumoperitoneum in patients undergoing laparoscopic cholecystectomy 108
First external quality assurance program of the Italian HLA-B*57:01 Network assessing the performance of clinical virology laboratories in HLA-B*57:01 testing 106
Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Uncontrolled Oncology Trials: A Comprehensive Review of the Literature 103
Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia 100
The role of sevoflurane exposure on systemic inflammation and neuroinflammation: a systematic review and meta-analysis of in vivo and in vitro studies 94
Recovery from deep neuromuscular blockade using different sugammadex doses in elderly patients undergoing laparoscopic robot-assisted prostatectomy 60
UGT1A1 and Sacituzumab Govitecan Toxicity: A Systematic Review and Meta‐Analysis 34
CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx) 27
UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics 16
Clopidogrel versus aspirin for coronary artery disease 15
Main factors associated with variability in the assessment of the objective response rate. A re-analysis of the PHEREXA phase 3 clinical trial 15
HLA genotype testing for carbamazepine, oxcarbazepine and eslicarbazepine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx) 14
Totale 10.812
Categoria #
all - tutte 35.805
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.805


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021170 0 0 0 0 0 0 0 0 0 57 95 18
2021/2022678 63 51 4 46 55 17 24 79 21 44 170 104
2022/20231.164 138 139 75 166 107 118 40 116 164 30 43 28
2023/2024750 42 149 33 86 40 101 72 21 9 38 73 86
2024/20251.322 29 37 95 45 104 81 37 62 243 121 255 213
2025/20263.262 451 105 220 421 525 204 628 175 277 256 0 0
Totale 10.812